Teachers Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Teachers Advisors’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$9.31M	Sell	134,190 -50,326	-27%	-$2.88M	0.01%	1032
2018 Q4	$8.02M	Buy	184,516 +2,606	+1%	+$142K	0.01%	1047
2018 Q3	$13.9M	Sell	181,910 -83,878	-32%	-$6.82M	0.02%	911
2018 Q2	$20.4M	Buy	265,788 +9,237	+4%	+$597K	0.03%	723
2018 Q1	$13.1M	Buy	256,551 +67,276	+36%	+$3.39M	0.02%	920
2017 Q4	$8.78M	Buy	189,275 +19,458	+11%	+$954K	0.01%	1096
2017 Q3	$9.04M	Sell	169,817 -69	-0%	-$4.09K	0.01%	1069
2017 Q2	$10.6M	Buy	169,886 +5,988	+4%	+$361K	0.01%	975
2017 Q1	$11.1M	Buy	163,898 +5,203	+3%	+$397K	0.02%	940
2016 Q4	$11.2M	Sell	158,695 -14,570	-8%	-$1.03M	0.02%	907
2016 Q3	$12.3M	Buy	173,265 +510	+0.3%	+$32.6K	0.02%	846
2016 Q2	$8.45M	Buy	172,755 +8,308	+5%	+$537K	0.01%	948
2016 Q1	$10.4M	Buy	164,447 +28,249	+21%	+$1.85M	0.02%	843
2015 Q4	$15.3M	Buy	136,198 +30,866	+29%	+$3.09M	0.03%	639
2015 Q3	$10.1M	Buy	105,332 +52,856	+101%	+$6.05M	0.02%	845
2015 Q2	$5.37M	Buy	52,476 +42,169	+409%	+$3.27M	0.01%	1144
2015 Q1	$640K	Buy	10,307 +927	+10%	+$51.5K	﹤0.01%	2291
2014 Q4	$412K	Hold	9,380	–	–	﹤0.01%	2543
2014 Q3	$531K	Hold	9,380	–	–	﹤0.01%	2367
2014 Q2	$421K	Sell	9,380 -300	-3%	-$12.4K	﹤0.01%	2526
2014 Q1	$473K	Buy	+9,680	New	+$498K	﹤0.01%	2436

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Teachers Advisors's RARE Position: Q1 2019 in Review

Teachers Advisors reduced its Ultragenyx Pharmaceutical (RARE) stake by 27% in Q1 2019, selling an estimated $2.88M and leaving 134,190 shares worth $9.31M. The position accounts for 0.01% of the portfolio, ranked #1032.

Teachers Advisors first reported a position in RARE in Q1 2014 and has held it in 21 quarters since. The position peaked at $20.4M in Q2 2018. 176 funds tracked by Wall St. Rank hold RARE as of Q1 2019.

Teachers Advisors held 134,190 shares of Ultragenyx Pharmaceutical worth $9.31M as of Q1 2019.
Teachers Advisors sold 50,326 Ultragenyx Pharmaceutical shares in Q1 2019, an estimated $2.88M.
Ultragenyx Pharmaceutical made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1032 holding.
Teachers Advisors first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 21 quarters since.
Teachers Advisors's Ultragenyx Pharmaceutical position peaked at $20.4M in Q2 2018.
176 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.